Literature DB >> 7864659

Lysophosphatidylcholine: a chemoattractant to human T lymphocytes.

A K Ryborg1, B Deleuran, K Thestrup-Pedersen, K Kragballe.   

Abstract

Various cell stimuli act through activation of phospholipase A2 resulting in the release of arachidonic acid, the precursor of eicosanoids, from the sn-2 position of cell membrane phospholipids. A byproduct of phospholipase A2 activity is the lysophospholipids which have been found to potentiate T-lymphocyte activation. The purpose of the present study was to determine whether the various lysophospholipids modulate the migration of peripheral normal human T lymphocytes in vitro. It was found that lysophosphatidylcholine (lysoPC) induced T-lymphocyte migration in the concentration range 10(-7) to 10(-4) M with a maximum at 10(-6) M (mean chemotactic index, 2.06). The migration was due to chemotaxis rather than chemokinesis. In contrast, lysophosphatidylethanolamine (lysoPE) and lysophosphatidylinositol (lysoPI) did not exhibit chemotactic properties towards T lymphocytes. Further studies showed that the length of the fatty acids in the sn-1 position as well as the presence of double bonds modulated the chemotactic ability. The lysoPC compound with the highest chemotactic activity was lysoPC;1-palmitoyl (C = 16:0). The results demonstrated that lysoPC, a phospholipase A2-generated hydrolysis product of phosphatidylcholine, induced T-lymphocyte chemotaxis in vitro. Because phosphatidylcholine is the major phospholipid in the epidermis, the activation of phospholipase A2 may result in the release of lysoPC in concentrations capable of inducing migration of T lymphocytes into the epidermis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7864659     DOI: 10.1007/bf00371572

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

1.  ATP-ase activity of purified human normal T- and B-lymphocytes.

Authors:  K Kragballe; J Ellegaard
Journal:  Scand J Haematol       Date:  1978-03

Review 2.  Psoriasis. Leukocytes and cytokines.

Authors:  K D Cooper
Journal:  Dermatol Clin       Date:  1990-10       Impact factor: 3.478

3.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C.

Authors:  Y Asaoka; M Oka; K Yoshida; Y Sasaki; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.

Authors:  K Fogh; T Herlin; K Kragballe
Journal:  J Allergy Clin Immunol       Date:  1989-02       Impact factor: 10.793

6.  Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.

Authors:  S Forster; E Ilderton; J F Norris; R Summerly; H J Yardley
Journal:  Br J Dermatol       Date:  1985-02       Impact factor: 9.302

7.  Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.

Authors:  B Grøn; L Iversen; V Ziboh; K Kragballe
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.

Authors:  N Kume; M I Cybulsky; M A Gimbrone
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation.

Authors:  Y Asaoka; M Oka; K Yoshida; Y Nishizuka
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

10.  Lysophosphatidylcholine induces mast cell secretion and protein kinase C activation.

Authors:  D L Marquardt; L L Walker
Journal:  J Allergy Clin Immunol       Date:  1991-11       Impact factor: 10.793

View more
  11 in total

1.  Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.

Authors:  Yi Xiao; F Peter Guengerich
Journal:  J Lipid Res       Date:  2012-05-16       Impact factor: 5.922

2.  Phospholipase A2 superfamily members play divergent roles after spinal cord injury.

Authors:  Rubèn López-Vales; Nader Ghasemlou; Adriana Redensek; Bradley J Kerr; Efrosini Barbayianni; Georgia Antonopoulou; Constantinos Baskakis; Khizr I Rathore; Violetta Constantinou-Kokotou; Daren Stephens; Takao Shimizu; Edward A Dennis; George Kokotos; Samuel David
Journal:  FASEB J       Date:  2011-08-25       Impact factor: 5.191

3.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Authors:  L Arbibe; K Koumanov; D Vial; C Rougeot; G Faure; N Havet; S Longacre; B B Vargaftig; G Béréziat; D R Voelker; C Wolf; L Touqui
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

4.  Metabolomic Analysis of Skin Biopsies from Patients with Atopic Dermatitis Reveals Hallmarks of Inflammation, Disrupted Barrier Function and Oxidative Stress.

Authors:  Liis Ilves; Aigar Ottas; Bret Kaldvee; Kristi Abram; Ursel Soomets; Mihkel Zilmer; Viljar Jaks; Külli Kingo
Journal:  Acta Derm Venereol       Date:  2021-02-24       Impact factor: 3.875

5.  Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory.

Authors:  Mi-Kyung Chang; Christoph J Binder; Yury I Miller; Ganesamoorthy Subbanagounder; Gregg J Silverman; Judith A Berliner; Joseph L Witztum
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

6.  Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.

Authors:  Kyle Farmer; Catherine A Smith; Shawn Hayley; Jeffrey Smith
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

7.  The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.

Authors:  Aigar Ottas; Dmytro Fishman; Tiia-Linda Okas; Külli Kingo; Ursel Soomets
Journal:  Arch Dermatol Res       Date:  2017-07-10       Impact factor: 3.017

8.  Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro.

Authors:  Gerhard E Grossmayer; Hildegard Keppeler; Sebastian Boeltz; Christina Janko; Jürgen Rech; Martin Herrmann; Kirsten Lauber; Luis E Muñoz
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

9.  UPLC-QTOF MS-Based Serum Metabolomic Profiling Analysis Reveals the Molecular Perturbations Underlying Uremic Pruritus.

Authors:  Qiong Wu; Huan Zhang; Jia-Rong Ding; Zhan-Ying Hong; Hao Wu; Zhen-Yu Zhu; Zhi-Yong Guo; Yi-Feng Chai
Journal:  Biomed Res Int       Date:  2018-01-10       Impact factor: 3.411

10.  Epidermal Overexpression of Xenobiotic Receptor PXR Impairs the Epidermal Barrier and Triggers Th2 Immune Response.

Authors:  Andreas Elentner; Matthias Schmuth; Nikolaos Yannoutsos; Thomas O Eichmann; Robert Gruber; Franz P W Radner; Martin Hermann; Barbara Del Frari; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2017-09-18       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.